Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-19

Clinical Trial Update: pErsonalised Nocebo Assessment of Beta-blockEr Symptoms in Heart Failure [NA]

View source ↗

Summary

An Imperial College London trial update notes a study investigating personalised nocebo effects related to beta-blocker symptoms in heart failure. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Imperial College London | Conditions: Side-Effect, Heart Failure | NA | Status: RECRUITING